What Icd-10-cm Code Is Reported For Elevated Psa

Understanding the ICD‑10‑CM Code Used for an Elevated PSA Result

An elevated prostate‑specific antigen (PSA) level is one of the most common laboratory findings that prompts further urological evaluation. Proper documentation of this abnormal result is essential for accurate billing, quality reporting, and coordination of care. Consider this: in the ICD‑10‑CM (International Classification of Diseases, 10th Revision, Clinical Modification) system, the specific code that captures an elevated PSA is R97. In practice, 2 – Elevated prostate specific antigen [PSA]. On top of that, this article explains when and how to use R97. 2, explores related coding considerations, and provides practical guidance for clinicians, coders, and medical billers who handle PSA testing in everyday practice.

1. Why Accurate Coding of an Elevated PSA Matters

Reimbursement: Health insurers require a diagnosis code that justifies the laboratory test and any subsequent procedures (e.g., prostate biopsy, imaging). Using the correct ICD‑10‑CM code helps confirm that claims are processed without delay.
Clinical Documentation Improvement (CDI): Precise coding reflects the true clinical picture, supporting quality metrics, risk adjustment, and population health initiatives.
Research and Public Health: Aggregated data on elevated PSA levels contribute to epidemiologic studies on prostate cancer screening and outcomes.

2. The Core Code: R97.2 – Elevated Prostate Specific Antigen

Element	Description
Code	R97.Day to day, 2
Descriptor	Elevated prostate specific antigen [PSA]
Category	Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified (R00‑R99)
Effective date	October 1, 2015 (first appearance in ICD‑10‑CM)
Excludes	R97. 0 (Abnormal blood‑forming function), R97.Now, 1 (Elevated blood level of tumor marker), R97. 8 (Other abnormal findings of blood chemistry), R97.9 (Abnormal finding of blood chemistry, unspecified).

Key points

R97.2 is a “finding” code, not a disease code. It should be paired with a symptom, condition, or preventive service that prompted the PSA test (e.g., “Routine health examination,” “Family history of prostate cancer,” or “Lower urinary tract symptoms”).
The code does not imply a diagnosis of prostate cancer; it merely records that the PSA value exceeds the laboratory’s reference range.
Use R97.2 only when the laboratory report specifically states “PSA elevated” or when the clinician documents the result as abnormal. If the PSA is within normal limits, no R97.2 code is appropriate.

3. When to Use R97.2 in Combination with Other Codes

3.1 Screening or Preventive Visits

Z12.5 – Encounter for screening for malignant neoplasm of prostate
- Pair R97.2 with Z12.5 when the PSA test is part of a routine prostate cancer screening protocol. Example: “Annual wellness visit, PSA 6.2 ng/mL (elevated).”

3.2 Symptomatic Presentations

R33.9 – Retention of urine, unspecified or R35.0 – Frequency of micturition
- If a patient presents with urinary symptoms and an elevated PSA, code both the symptom and the elevated PSA.
N40.0 – Benign prostatic hyperplasia (BPH) with lower urinary tract symptoms
- Document BPH as the underlying condition, and add R97.2 to indicate the PSA abnormality.

3.3 Known Prostate Cancer

C61 – Malignant neoplasm of prostate
- When a patient already has a prostate cancer diagnosis and the PSA is used for monitoring, R97.2 is NOT appropriate. Instead, use Z85.46 – Personal history of malignant neoplasm of prostate (if the patient is in remission) or simply code the cancer diagnosis with the appropriate encounter code.

3.4 Family History or Genetic Risk

Z80.42 – Family history of malignant neoplasm of prostate
- If the elevated PSA prompted a referral due to a strong family history, code the family history plus R97.2.

4. Documentation Tips for Clinicians

Explicitly state the PSA value and its interpretation.
- “PSA = 7.8 ng/mL (elevated, reference ≤ 4.0 ng/mL).”
Mention the reason for ordering the test.
- “Screening PSA performed as part of annual wellness exam.”
Link the finding to the clinical context.
- “Patient reports nocturia; elevated PSA noted, plan for urology referral.”
Avoid ambiguous language.
- Phrases like “PSA was high” without a numeric value may lead to coding uncertainty.

5. Coding Workflow: From Lab Result to Claim Submission

Lab Interface – The electronic health record (EHR) receives the PSA result flagged as “high.”
Provider Review – Clinician confirms the result, documents the interpretation, and decides on next steps (e.g., repeat test, imaging).
Coder Assignment – The coder selects R97.2 and adds any accompanying diagnosis or encounter codes (Z12.5, R33.9, etc.).
Claim Generation – The claim package includes CPT code 84153 (PSA; total) or 84154 (free PSA) along with the ICD‑10‑CM codes.
Audit Trail – Periodic internal audits verify that R97.2 is only used when the lab report explicitly indicates an elevated PSA.

6. Frequently Asked Questions (FAQ)

Q1. Is R97.2 used for both total and free PSA results?
A: Yes. The code refers to any PSA measurement reported as elevated, regardless of whether it is total, free, or a ratio.

Want to learn more? We recommend why is police called 12 and words that start with a and end with r for further reading.

Q2. What if the PSA is borderline (e.g., 4.1 ng/mL) and the provider decides to repeat the test?
A: If the provider documents the result as “elevated” or “above normal range,” R97.2 is appropriate. If the result is described as “borderline, will repeat,” consider using R79.9 – Other abnormal findings of blood chemistry until a definitive interpretation is made.

Q3. Can R97.2 be used for a PSA test ordered for monitoring known prostate cancer?
A: No. In the context of cancer surveillance, the PSA is a tumor marker, and the appropriate code is R97.1 – Elevated blood level of tumor marker or simply the cancer diagnosis code (C61).

Q4. Does the presence of prostatitis affect coding?
A: If prostatitis is diagnosed clinically, code N41.0 – Acute prostatitis or N41.1 – Chronic prostatitis as needed, and still add R97.2 if the PSA is elevated.

Q5. How should coders handle an elevated PSA that is later found to be a laboratory error?
A: If the error is corrected and the final result is normal, the claim should be amended to remove R97.2 and replace it with an appropriate normal finding code (e.g., R79.9). Documentation of the correction is essential.

7. Common Coding Pitfalls and How to Avoid Them

Pitfall	Why It Happens	Correct Approach
Using R97.And 2 for a normal PSA	Misinterpretation of “PSA ordered” as “PSA abnormal. ”	Verify the lab comment “within normal limits” before assigning R97.But 2.
Pairing R97.2 with C61 (prostate cancer) without justification	Assuming any elevated PSA equals cancer.	Use R97.1 for tumor marker elevation or omit R97.In real terms, 2 if PSA is used solely for monitoring known cancer. Still,
Omitting the preventive encounter code (Z12. 5) during routine screening	Focus on lab result only.	Add Z12.5 whenever the PSA is part of a screening protocol.
Selecting R79.9 (abnormal finding of blood chemistry) instead of R97.Even so, 2	Lack of familiarity with specific PSA code. That's why	Remember that R97. On top of that, 2 is the dedicated code for elevated PSA; reserve R79. 9 for non‑specific lab abnormalities. But
Not documenting the numeric PSA value	Incomplete charting.	Include the exact PSA number and reference range in the note.

8. Impact on Quality Measures and Reporting

Many health systems track prostate cancer screening rates and follow‑up compliance for elevated PSA results. Accurate use of R97.2 enables:

HEDIS measure “Prostate Cancer Screening” – The denominator includes men aged 55‑69 with at least one PSA test; the numerator captures those with a normal result. Elevated PSA cases coded with R97.2 help identify patients who need diagnostic follow‑up.
CMS Quality Payment Program (QPP) – Clinical Quality Measures (CQMs) – Correct coding supports the “Screening for Prostate Cancer” measure, influencing value‑based reimbursement.

9. Real‑World Example: From Encounter to Claim

Patient: 62‑year‑old male, routine annual exam.
Reason for visit: “Wellness visit, no complaints.”
Lab order: PSA (total).
Result: 6.4 ng/mL (reference ≤ 4.0 ng/mL).
Provider note: “PSA elevated at 6.4 ng/mL. Discussed risk of prostate cancer; recommended urology referral for possible biopsy.”

Coding:

CPT 84153 – PSA, total.
ICD‑10‑CM:
- Z12.5 – Encounter for screening for malignant neoplasm of prostate.
- R97.2 – Elevated prostate specific antigen [PSA].
- Z80.42 – Family history of malignant neoplasm of prostate (if applicable).

The claim is submitted with these codes; the payer validates that an elevated PSA justifies the screening encounter and subsequent referral, leading to prompt reimbursement.

10. Conclusion

The ICD‑10‑CM code R97.2. Clinicians should document the numeric PSA value, its interpretation, and the clinical context, while coders must verify that the lab report explicitly indicates elevation before assigning R97.Proper utilization of this code, in conjunction with relevant encounter or symptom codes, ensures accurate billing, supports quality reporting, and reflects the true clinical scenario. Because of that, 2 – Elevated prostate specific antigen [PSA] is the precise diagnostic code for documenting an abnormal PSA result. By adhering to these best practices, healthcare teams can minimize claim denials, improve data integrity for research, and ultimately provide better, more coordinated care for patients undergoing prostate health evaluation.